Vriens, B. E. P. J.
Vriens, I. J. H.
Aarts, M. J. B.
van Gastel, S. M.
van den Berkmortel, F. W. P. J.
Smilde, T. J.
van Warmerdam, L. J. C.
van Spronsen, D. J.
Peer, P. G. M.
de Boer, M.
Tjan-Heijnen, V. C. G.
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer
https://doi.org/10.1007/s10549-017-4364-8
Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer
https://doi.org/10.1016/j.ejca.2015.10.010
Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer
https://doi.org/10.1016/j.ejca.2013.06.012
Article History
Received: 26 April 2017
Accepted: 27 June 2017
First Online: 3 July 2017
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: This study was conducted in accordance with the Declaration of Helsinki and the principles of Good Clinical Practice.
: Written informed consent was obtained from all individuals before inclusion.